Polsky Bruce — SEC insider filings
SEC reporting owner CIK 1508458. 10 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2020-10-30 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 3 filings — 67,520 shares, $264,538 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 18,252 shares @ $3.95 ($72,099) in Atea Pharmaceuticals, Inc., filed 2026-11-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | Director | 10 | — | 5 legs · 67,520 sh · $264,538 | 23 |
Insider filings — Polsky Bruce
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Sale (S): 8,750 @ $4.03 | EDGAR |
| 2026-11-18 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 48,028 @ $1.24 · Sale (S): 14,254 @ $4.27 · Option exercise (M): 8,720 @ $1.24 · Sale (S): 8,720 @ $4.03 · Option exercise (M): 18,252 @ $1.24 · Sale (S): 18,252 @ $3.95 · +3 more | EDGAR |
| 2026-06-23 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Option exercise (M): 29,600 (derivative) @ $0 · Grant/award (A): 26,700 (derivative) @ $0 · Grant/award (A): 37,700 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 29,600 @ $0 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 · Option exercise (M): 29,600 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Sale (S): 17,544 @ $3.49 · Grant/award (A): 29,600 (derivative) @ $0 · Grant/award (A): 41,200 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Option exercise (M): 33,150 @ $0 · Option exercise (M): 33,150 (derivative) @ $0 | EDGAR |
| 2023-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 33,150 (derivative) @ $0 · Grant/award (A): 46,750 (derivative) @ $0 | EDGAR |
| 2022-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 61,264 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 34,025 (derivative) @ $0 | EDGAR |
| 2020-10-30 | 4 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-04 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1508458 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs